We are live on
!
Find out more
Kymera Therapeutics
KYMR
KYMR
110 hedge funds and large institutions have $1.29B invested in Kymera Therapeutics in 2021 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 45 increasing their positions, 16 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
15,471% more call options, than puts
Call options by funds: $7.47M | Put options by funds: $48K
181% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 16
54% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 24
45% more capital invested
Capital invested by funds: $887M → $1.29B (+$400M)
13% more funds holding
Funds holding: 97 → 110 (+13)
8% more ownership
Funds ownership: 50.95% → 58.95% (+8%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
110
Holders Change
+13
Holders Change %
+13.4%
% of All Funds
1.91%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
37
Increased
45
Reduced
16
Closed
24
Calls
$7.47M
Puts
$48K
Net Calls
+$7.43M
Net Calls Change
+$7.43M
Top Buyers
| 1 |
BlackRock
New York
|
+$40.6M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$39.6M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
+$18.2M |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$17.8M |
| 5 |
State Street
Boston,
Massachusetts
|
+$17.4M |
Top Sellers
| 1 |
DIC
Deer IX & Co
Larchmont,
New York
|
-$18.5M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$15.5M |
| 3 |
Morgan Stanley
New York
|
-$12.5M |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$10.1M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.38M |
